News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Kristina Jankovic: FDA approved datopotamab, deruxtecan-dlnk for unresectable, metastatic, HR+ HER2- breast cancer
Kristina Jankovic/X
Jan 20, 2025, 13:56

Kristina Jankovic: FDA approved datopotamab, deruxtecan-dlnk for unresectable, metastatic, HR+ HER2- breast cancer

Kristina Jankovic, Medical Oncology Resident at University Clinical Center Nis, shared a post on X:

“DC Approval!! US FDA approved datopotamab, deruxtecan-dlnk for unresectable, metastatic, HR+ HER2- Breast Cancer previously treated with endocrine and chemotherapy for unresectable, metastatic disease. ”

Kristina Jankovic: FDA approved datopotamab, deruxtecan-dlnk for unresectable, metastatic, HR+ HER2- breast cancer

Additional Information

cancer Kristina Jankovic OncoDaily Oncology
Special Coverage
Blog
Apr 4, 2025, 15:12
Julia Ruthus: What does holistic survivorship care in metastatic breast cancer look like? 
Blog
Apr 4, 2025, 15:01
Robyn Payne: Navigating the Future of Head and Neck Cancer - Together
Blog
Apr 4, 2025, 14:54
Kidney Cancer Research Summit 2025: Advancing Science and Collaboration
Blog
Apr 4, 2025, 14:23
Prashant Kumar: Integrating Science and Care - Pioneering the Future of Oncology at South Asian University
Science
Apr 4, 2025, 14:21
Myeloma Paper of the Day, April 4th, suggested by Robert Orlowski
Blog
Apr 4, 2025, 14:17
Raffaella Casolino: The second World Health Organization global clinical trials forum
Blog
Apr 4, 2025, 14:13
Wafik El-Deiry: Great to see Dr. Laura Goldberg Speak at Legorreta Cancer Center TRDG Meeting
Oncolibrary
Apr 4, 2025, 13:58
New Paper Alert: SMART ONE Trial: Single Fraction MR-Guided SBRT for Visceral Tumors
Blog
Apr 4, 2025, 13:57
Carmen Monge-Montero: Alma Seidel shares an insight for parents navigating the emotional weight of childhood cancer
Blog
Apr 4, 2025, 13:45
Introducing AIEOP's 2024-2027 Working Group Coordinators - Andrea Ferrari
Drugs
Apr 4, 2025, 13:43
Sotorasib (Lumakras): What Patients need to know?
Blog
Apr 4, 2025, 13:12
First quarter of POHER's newsletter is out